Human Capital Disclosure Assessment
KISSEI PHARMACEUTICAL CO.,LTD.
Assessment Scores
Company coverage reference date: 2026-08-31
Overall Score
| Disclosure Governance | 18.75 / 20 |
|---|---|
| Human Intangible Assets | 27.5 / 40 |
| Technical Knowledge | 8.75 / 10 |
| Skills | 5.0 / 15 |
| Motivation | 13.75 / 15 |
| Human Capital Investment Flow | 12.5 / 40 |
Overall Disclosure Profile
KISSEI PHARMACEUTICAL CO.,LTD. specifically identifies specialist personnel needed for its growth strategy in drug discovery, development, pharmaceutical information provision, and DX. It assesses the DX capabilities of all employees annually. In FY2025, 40.8% were at or above the "core tier," able to use data and IT in their work. It reflects roles and conduct in compensation and provides careers for both managers and highly specialized personnel.
Its employee attitude survey presents the questions and defines positive responses, comparing FY2022 and FY2025. The response to "I find my current work rewarding" was 87.3%. The response to "I propose and implement necessary work beyond my objectives" was 91.4%, providing specific indications of work motivation and capability application. However, disclosure is limited regarding the extent of practical skill usage and the calculation basis for business outcomes and effects corresponding to human capital initiatives.
Scores by Assessment Item
Scores assess disclosures in the Annual Securities Report. A score of zero does not mean that an initiative is not implemented or that employees lack capability.
| Disclosure Governance | |
|---|---|
| G1Disclosure of Basic Quantitative Information | 5 / 5 |
| G2Governance and Risk Management | 3.75 / 5 |
| G3Human Capital Strategy and Basic Policy | 5.0 / 5 |
| G4Clarity of Indicators, Targets, and Explanations | 5.0 / 5 |
| Human Intangible Assets | |
| Technical Knowledge | |
| T1Technical Knowledge Base | 5.0 / 5 |
| T2Acquisition and Accumulation of Technical Knowledge | 3.75 / 5 |
| Skills | |
| S1Alignment between Technical Knowledge and Practical Work | 2.5 / 5 |
| S2Volume of Use and Application | 0.0 / 5 |
| S3Continued Use and Expansion | 2.5 / 5 |
| Motivation | |
| M1Mechanisms Supporting Motivation | 5.0 / 5 |
| M2Track Record of Operation | 3.75 / 5 |
| M3Employee State and Change | 5.0 / 5 |
| Human Capital Investment Flow | |
| F1Logic from Investment to Outcomes | 5.0 / 10 |
| F2Magnitude of Outcomes | 0.0 / 10 |
| F3Calculation Basis and Use in Planning | 0.0 / 10 |
| F4Verification of the Relationship | 7.5 / 10 |
Assessment History
2025-04-01 – 2026-03-31 · Latest recorded assessment
No earlier assessments are recorded. Comparability across periods has not been confirmed.
Sources & Assessment Scope
Current Company Information
Filing Information
Assessment Scope & Disclaimer
This assessment is based solely on information disclosed in the company's Japanese-language Annual Securities Report filed through EDINET.
It does not assess the human capital initiatives a company actually implements or the company's human capital capabilities themselves.
Items for which no disclosure was identified in the Annual Securities Report receive no points, regardless of whether the company actually implements the relevant initiatives.
This English-language assessment is a translation of the original Japanese assessment and is provided for convenience. In the event of any discrepancy, the Japanese assessment prevails.